Mexican cervical cancer rates down 5% for third year running
This article was originally published in Clinica
Mexico has recorded a 5% reduction in cervical cancer rates in each of the last three years, putting it on track to cut the number of deaths from 4,100 in 2006, to 3,200 in 2012. So said health minister José �ngel C�rdova Villalobos, during an official visit to the state of Tabasco this week. He used the figures to highlight the "fundamental need" for women to come forward for screening, so as to help "eradicate the disease".
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.